Gene expression profiling in equine polysaccharide storage myopathy revealed inflammation, glycogenesis inhibition, hypoxia and mitochondrial dysfunctions.
BACKGROUND
Several cases of myopathies have been observed in the horse Norman Cob breed. Muscle histology examinations revealed that some families suffer from a polysaccharide storage myopathy (PSSM). It is assumed that a gene expression signature related to PSSM should be observed at the transcriptional level because the glycogen storage disease could also be linked to other dysfunctions in gene regulation. Thus, the functional genomic approach could be conducted in order to provide new knowledge about the metabolic disorders related to PSSM. We propose exploring the PSSM muscle fiber metabolic disorders by measuring gene expression in relationship with the histological phenotype.


RESULTS
Genotypying analysis of GYS1 mutation revealed 2 homozygous (AA) and 5 heterozygous (GA) PSSM horses. In the PSSM muscles, histological data revealed PAS positive amylase resistant abnormal polysaccharides, inflammation, necrosis, and lipomatosis and active regeneration of fibers. Ultrastructural evaluation revealed a decrease of mitochondrial number and structural disorders. Extensive accumulation of an abnormal polysaccharide displaced and partially replaced mitochondria and myofibrils. The severity of the disease was higher in the two homozygous PSSM horses.Gene expression analysis revealed 129 genes significantly modulated (p < 0.05). The following genes were up-regulated over 2 fold: IL18, CTSS, LUM, CD44, FN1, GST01. The most down-regulated genes were the following: mitochondrial tRNA, SLC2A2, PRKCalpha, VEGFalpha. Data mining analysis showed that protein synthesis, apoptosis, cellular movement, growth and proliferation were the main cellular functions significantly associated with the modulated genes (p < 0.05). Several up-regulated genes, especially IL18, revealed a severe muscular inflammation in PSSM muscles. The up-regulation of glycogen synthase kinase-3 (GSK3beta) under its active form could be responsible for glycogen synthase (GYS1) inhibition and hypoxia-inducible factor (HIF1alpha) destabilization.


CONCLUSIONS
The main disorders observed in PSSM muscles could be related to mitochondrial dysfunctions, glycogenesis inhibition and the chronic hypoxia of the PSSM muscles.
Barrey
Eric
E
Unité de Biologie Intégrative des Adaptations à l'Exercice -INSERM 902, Genopole Evry, France. eric.barrey@inserm.fr
Mucher
Elodie
E
Jeansoule
Nicolas
N
Larcher
Thibaut
T
Guigand
Lydie
L
Herszberg
Bérénice
B
Chaffaux
Stéphane
S
Guérin
Gérard
G
Mata
Xavier
X
Benech
Philippe
P
Canale
Marielle
M
Alibert
Olivier
O
Maltere
Péguy
P
Gidrol
Xavier
X
D000818:Animals; D005260:Female; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D005838:Genotype; D006003:Glycogen / Q000378:metabolism*; D006734:Horse Diseases / Q000503:physiopathology*; D006736:Horses; D000860:Hypoxia / Q000209:etiology / Q000662:veterinary*; D007249:Inflammation / Q000209:etiology / Q000503:physiopathology; D008297:Male; D008928:Mitochondria / Q000473:pathology*; D018482:Muscle, Skeletal / Q000503:physiopathology; D009135:Muscular Diseases / Q000150:complications / Q000503:physiopathology / Q000662:veterinary*; D010641:Phenotype; D011134:Polysaccharides / Q000378:metabolism*
D011134:Polysaccharides; D006003:Glycogen